Search research articles
Contact Us
Filters
Showing results (131-140 of 456) with videos related to
Page
of 46
Sort By:
Hepatology International
|
February 3, 2011
Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
Jeng-Fu Yang, Yi-Hui Kao, Chia-Yen Dai, et al.
Journal of Hepatology
|
February 24, 2009
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
Chia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Plos One
|
November 6, 2018
Association of hyperuricemia with disease severity in chronic hepatitis C patients
Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, et al.
Plos One
|
April 4, 2015
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients
Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, et al.
Hepatology International
|
November 15, 2018
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International
|
July 24, 2015
Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics
Chung-Feng Huang, Ming-Lun Yeh, Jia-Jung Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
November 17, 2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, et al.
International Journal of Medical Sciences
|
April 2, 2014
Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients
Jer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, et al.
BMC Infectious Diseases
|
April 13, 2005
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma
Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Page
of 46
Search research articles
Search
Showing results (131-140 of 456) with videos related to
Sort By:
Page
of 46
Hepatology International
|
February 3, 2011
Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
Jeng-Fu Yang, Yi-Hui Kao, Chia-Yen Dai, et al.
Journal of Hepatology
|
February 24, 2009
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
Chia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Plos One
|
November 6, 2018
Association of hyperuricemia with disease severity in chronic hepatitis C patients
Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, et al.
Plos One
|
April 4, 2015
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients
Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, et al.
Hepatology International
|
November 15, 2018
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International
|
July 24, 2015
Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics
Chung-Feng Huang, Ming-Lun Yeh, Jia-Jung Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
November 17, 2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, et al.
International Journal of Medical Sciences
|
April 2, 2014
Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients
Jer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, et al.
BMC Infectious Diseases
|
April 13, 2005
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma
Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Page
of 46